Related Experiment Video
Updated: Jul 18, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Aging and cardiac implantable electronic device complications: is the procedure safe in older patients?
Tuncay Güzel1, Adem Aktan2, Raif Kılıç3
1Department of Cardiology, Health Science University, Gazi Yaşargil Training and Research Hospital, 21070, Diyarbakır, Turkey. drtuncayguzel@gmail.com.
Insights
Older patients (≥75 years) undergoing cardiac implantable electronic device (CIED) procedures had higher infection rates. Careful pre- and post-procedure evaluation for infection is crucial in this demographic.
Area of Science:
- Cardiology
- Medical Devices
- Geriatric Medicine
Background:
- Cardiac implantable electronic devices (CIEDs) are crucial for managing various cardiac conditions.
- Assessing procedural complication risks in elderly populations is vital for patient safety.
- This study compares complication incidence in patients aged ≥75 years versus <75 years undergoing CIED procedures.
Purpose of the Study:
- To determine if older patients (≥75 years) experience a higher incidence of complications following cardiac implantable electronic device (CIED) procedures compared to younger patients (<75 years).
Main Methods:
- A retrospective cohort study was conducted involving 1923 patients who underwent CIED procedures between January 2011 and May 2023.
- Patients were stratified into two groups: <75 years and ≥75 years.
- The primary composite endpoint included clinically significant hematoma, pericardial effusion/tamponade, pneumothorax, and device-related infection.
Main Results:
- No significant difference was observed in the overall primary composite endpoint between the age groups (3.5% vs. 4.4%, p=0.393).
- Device-related infection rates were significantly higher in the older group (1.8% vs. 3.4%, p=0.034).
- No significant differences were found for clinically significant hematoma or pneumothorax between the age groups.
Conclusions:
- Infection rates were notably higher in patients aged 75 years and older.
- This elderly patient group requires heightened vigilance for infection development, both before and after CIED procedures.
- Multivariate analysis did not identify age ≥75 years as an independent risk factor for device-related infection.
Background:
In this study, we investigated whether there is a higher incidence of cardiac implantable electronic devices (CIED) procedures related complications in older (≥ 75 years) than in younger (< 75 years) patients.
Methods:
This retrospective cohort study enrolled patients who had undergone CIED procedures (de novo implantation, system upgrade, generator substitution, pocket revision or lead replacement) at two heart centers in Turkey between January 2011 and May 2023. The primary composite endpoint included clinically significant hematoma (CSH), pericardial effusion or tamponade, pneumothorax, and infection related to the device system. Secondary outcomes included each component of the composite end point.
Results:
The overall sample included 1923 patients (1419 < 75 years and 504 aged ≥ 75 years). There was no difference between the groups in terms of cumulative events defined as primary outcome (3.5% vs. 4.4%, p = 0.393). Infection related to device system was significantly higher in the ≥ 75 age group (1.8% vs. 3.4%, p = 0.034). There was no significant difference between the groups in terms of clinically significant hematoma and pneumothorax (0.7% vs. 0.4%, p = 0.451, 1.4% vs. 1.0%, p = 0.477, respectively). In multivariate model analysis, no association was found between age ≥ 75 years and infection related to the device system.
Conclusion:
Infection rates were relatively higher in the patient group aged ≥ 75 years. This patient group should be evaluated more carefully in terms of infection development before and after the procedure.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Heart Failure VI: Adjunct Therapies
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

